Recommendations for management of diabetes during Ramadan

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2305-2311

  Al Arouj, Monira ^a   Bouguerra, Radhia ^b   Buse, John ^c   Hafez, Sherif ^d   Hassanein, Mohamed ^e   Ibrahim, Mahmoud Ashraf ^f,o   Ismail Beigi, Faramarz ^g   El Kebbi, Imad ^h   Khatib, Oussama ⁱ   Kishawi, Suhail ^j   Al Madani, Abdulrazzaq ^k   Mishal, Aly A ^l   Al Maskari, Masoud ^m   Nakhi, Abdalla Ben ^a   Al Rubean, Khaled ⁿ  

^a AL AMIRI HOSPITAL   (Kuwait)

^b Institut National de Nutrition Tunis   (Tunisia)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d CAIRO UNIVERSITY   (Egypt)

^e GLAN CLWYD HOSPITAL   (United Kingdom)

^f Egyptian Diabetes Center   (Egypt)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j Ministry of Health Palestine   (Palestine)

^k DUBAI HOSPITAL   (United Arab Emirates)

^l Islamic Hospital   (Jordan)

^m SULTAN QABOOS UNIVERSITY   (Oman)

ⁿ KING SAUD UNIVERSITY   (Saudi Arabia)

^o NONE   (Egypt)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; IFTAR; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SUHUR; SULFONYLUREA DERIVATIVE;

DEHYDRATION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DIETARY INTAKE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MOSLEM; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; RAMADAN; RELIGION; REVIEW; THROMBOSIS;

DIABETES MELLITUS; FASTING; HUMANS; ISLAM; PATIENT EDUCATION; SELF CARE;

EID: 24144497149     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2305     Document Type: Review

References (30)

1. The Canadian Society of Muslims: Muslim population statistics [article online], 2000. Available from http://muslim-canada.org/muslimstats.html. Accessed 14 April 2005
2. An analysis of the world Muslim population by country/region [article online]. Available at http://www.factbook.net/ muslim_pop.php. Accessed 14 April 2005
3. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
4. Salti I, Benard E, Detoumay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, the EPIDIAR Study Group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27:2306-2311, 2004
5. International Meeting on Diabetes and Ramadan Recommendations: Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan. Casablanca, Morocco, FRSMR, 1995
6. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes (Review). Diabetes Care 26:1902-1912, 2003
7. Uysal AR, Erdogan MF, Sahin G, Kamel N, Erdogan G: Clinical and metabolic effects of fastingin 41 type 2 diabetic patients during Ramadan (Letter). Diabetes Care 21:2033-2034, 1998
8. Laajam MA: Ramadan fasting and non-insulin-dependent diabetes: effect on metabolic control. East Afr Med J 67:732-736, 1990
9. Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH: A study of the fasting diabetic patient during the month of Ramadan. Med J Malaysia 45:14-17, 1990
10. Belkhadir J, el Ghomari H, Klocker N, Mikou A, Nasciri M, Sabri M: Muslims with non-insulin-dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 307:292-295, 1993
11. Katibi IA, Akande AA, Bojuwoye BJ, Okesina AB: Blood sugar control among fasting Muslims with type 2 diabetes mellitus in Ilorin. Niger J Med 10:132-134, 2001
12. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
13. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:466-471, 1999
14. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM: Hypoglycemia in patients with type 2 diabetes. Arch Int Med 161:1653-1659, 2001
15. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
16. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 287:2570-2581, 2002
17. Akhan G, Kutluhan S, Koyuncuoglu HR: Is there any change in stroke incidence during Ramadan? Acta Neurol Scandin 101:259-261, 2000
18. Alghadyan AA: Retinal vein occlusion in Saudi Arabia: possible role of dehydration. Ann Ophthalmol 25:394-398, 1993
19. Temizhan A, Donderici O, Ouz D, Demirbas B: Is there any effect of Ramadan fasting on acute coronary heart disease events? Int J Cardiol 70:149-153, 1999
20. Writing team for the Diabetes Control and Complications Trial/Epidemiology for Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159-2167, 2003
21. Mucha GT, Merkel S, Thomas W, Bantle JP: Fasting and insulin glargine in individuals with type 1 diabetes (Brief Report). Diabetes Care 27:1209-1210, 2004
22. Kadiri A, Al-Nakhi A, El-Ghazali S, Jabbar A, Al Arouj M, Akram J, Wyatt J, Assem A, Ristic S: Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab 27:482-486, 2001
23. Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM: GUIDE study: double-blind comparison of once-daily glidazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 34:535-542, 2004
24. Sari R, Balci MK, Akbas SH, Avci B: The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 30:169-177, 2004
25. Mafauzy M: Repaglinide versus glibenclamide treatment of type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 58:45-53, 2002
26. Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Ekangaki A, Levitt LK, Liong LH, Rais N, Tounsi H, the Ramadan Study Group: A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Res Clin Pract 59:137-143, 2003
27. Akram J, De Verga V: Insulin lispro in the treatment of diabetes during the fasting month of Ramadan. Diabet Med 16:861-866, 1999
28. Malhotra APH, Scott J, Scott H, Wharton BA: Metabolic changes in Asian Muslim pregnant mothers observing Ramadan fast in Britain. Br J Nutr 61:663-672, 1989
29. Azizi F: Research in Islamic fasting and health. Ann Saudi Med 22:186-191, 2002
30. Akbani MF, Saleem M, Gadit WU, Ahmed M, Basil A, Malik RA: Fasting and feasting safely during Ramadan in the diabetic patient. Pract Diab Int 22:100-104, 2005